This disposition is nonprecedential
PER CURIAM.
The U.S. Patent and Trademark Office, Patent Trial and Appeal Board (Board), affirmed the examiner's rejection of all claims in U.S. Patent Application No. 11/145,716 ('716 application). This court reverses the Board's anticipation and obviousness determinations and remands.
I.
On June 6, 2005, Kevin Eaton filed the '716 application, entitled "Treatment of Dermatological Conditions." The ...
Let's get started
![Leagle.com](https://www.leagle.com/images/logo.png)
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.